EBS - The 1 Promising Coronavirus Stock No One Knows About Yet
Since the coronavirus pandemic first started making waves in January, the number of companies working to develop a treatment has skyrocketed. More than 160 potential COVID-19 vaccines are currently in development, and that figure doesn't even include other types of treatment (such as antivirals).
However, not all companies working in this area have received equal coverage. Perhaps the least-known COVID-19 stock on the market right now is a small Israel-based biotech company called Kamada (NASDAQ: KMDA). Here's what you need to know about this little biotech, and whether it truly stands a chance against its other, better-known competitors.
Image source: Getty Images.